Lack of serotonergic modulation on 3H-imipramine binding sites in basal conditions and during prolonged treatment with desmethylimipramine
Brunello, N.; Rovescalli, A.C.; Riva, M.; Racagni, G.
Psychopharmacology Bulletin 22(3): 931-936
1986
ISSN/ISBN: 0048-5764 PMID: 3025915 Document Number: 284869
Document emailed within 1 workday
Related Documents
Duncan, G.E.; Paul, I.A.; Powell, K.R.; Fassberg, J.B.; Stumpf, W.E.; Breese, G.R. 1989: Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites Journal of Pharmacology and Experimental Therapeutics 248(1): 470-477Scotto di Tella, A.M.; Levy, C.; Lacarelle, B.; Tissot, R. 1986: Binding of tritiated imipramine to human platelets. 1 or several binding sites? L'Encephale 12(1): 13-17
Baron, M.; Barkai, A.; Gruen, R.; Kowalik, S.; Quitkin, F. 1983: 3H-imipramine platelet binding sites in unipolar depression Biological Psychiatry 18(12): 1403-1409
Hrdina, P.D. 1989: Imipramine binding sites in brain and platelets: role in affective disorders International Journal of Clinical Pharmacology Research 9(2): 119-122
Ei-Fakahany, E.F.; Miller, E.R.; Abbassy, M.A.; Eldefrawi, A.T.; Eldefrawi, M.E. 1983: Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor Journal of Pharmacology and Experimental Therapeutics 224(2): 289-296
Schoemaker, H.; Boles, R.G.; Roeske, W.R.; Yamamura, H.I. 1983: Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain Proceedings of the Western Pharmacology Society 26: 219-224
Majewska, M.D.; Chuang, D.M. 1984: Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms Molecular Pharmacology 25(3): 352-359
Minchin, R.F.; Barber, H.E.; Ilett, K.F. 1982: Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydroxytryptamine and beta-phenylethylamine in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(4): 356-360
Gandolfi, O.; Barbaccia, M.L.; Costa, E. 1984: Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 229(3): 782-786
Dziedzicka-Wasylewska, M.; Papp, M. 1996: Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous Met-enkephalin in the rat dopaminergic mesolimbic system Polish Journal of Pharmacology 48(1): 53-56
Tiozzo, R.; Reggiani, D.; Croce, M.A.; Calandra, S.; Osima, B.; Bianchini, P. 1997: Effect of heparin on cell proliferation: lack of correlation with heparin binding sites on cell membrane Drugs under Experimental and Clinical Research 23(3-4): 103-109
Maj, J.; Rogóz, Z.; Skuza, G.; Sowińska, H. 1989: The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice Polish Journal of Pharmacology and Pharmacy 41(4): 313-319
McCann, D.J.; Su, T.P. 1991: Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes Journal of Pharmacology and Experimental Therapeutics 257(2): 547-554
Van Nueten, J.M.; Janssens, W.J.; Xhonneux, R.; Janssen, P.A. 1988: Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites Journal of Cardiovascular Pharmacology 11(Suppl 1): S10-S15
Bluth, R.; Langnickel, R.; Ott, T. 1985: Modulation by dopaminergic and serotonergic systems of cholinergic interneurons in nucleus accumbens and striatum Polish Journal of Pharmacology and Pharmacy 37(6): 753-763
Ramkumar, V.; el-Fakahany, E.E. 1985: Changes in the affinity of [3H]nimodipine binding sites in the brain upon chlorpromazine treatment and subsequent withdrawal Research Communications in Chemical Pathology and Pharmacology 48(3): 463-466
Olsen, R.W.; Bergman, M.O.; Van Ness, P.C.; Lummis, S.C.; Watkins, A.E.; Napias, C.; Greenlee, D.V. 1981: Gamma-Aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites Molecular Pharmacology 19(2): 217-227
Sleight, A.J.; Carolo, C.; Petit, N.; Zwingelstein, C.; Bourson, A. 1995: Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment Molecular Pharmacology 47(1): 99-103
Wernert, N.; Goebbels, R.; Seitz, G.; Dhom, G. 1986: Immunohistochemical demonstration of binding sites for peanut lectin (PNA) in prostatic carcinoma before and after antiandrogenic treatment Verhandlungen der Deutschen Gesellschaft für Pathologie 70: 329-331
Reith, M.E.; Sershen, H.; Allen, D.L.; Lajtha, A. 1983: A portion of [3H]cocaine binding in brain is associated with serotonergic neurons Molecular Pharmacology 23(3): 600-606